Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma.
Primary effusion lymphoma (PEL) selectively involves the serous body cavities, occurs predominantly in immunodeficient patients and is infected consistently by human herpesvirus type-8. PEL is also frequently infected by Epstein-Barr virus (EBV). The precise pathogenetic role of EBV coinfection in PEL is not fully understood. The lymphoma fails to express the EBV transforming proteins EBNA-2 and LMP-1, whereas it expresses EBNA-1 (latency I phenotype). Some studies have hypothesized that other EBV-positive lymphomas expressing the latency I phenotype may associate with specific molecular variants of EBNA-1, although this issue has not been addressed in PEL. On this basis, this study is aimed at a detailed molecular characterization of EBV in PEL. Fifteen EBV positive PEL (12 AIDS-related, one post-transplant, two arising in immunocompetent hosts) were subjected to molecular characterization of the viral genes EBNA-1 and LMP-1, as well as definition of EBV type-1/type-2. The EBNA-1 gene displayed a high degree of heterogeneity in different cases of PEL, with seven distinct recognizable variants and subvariants. A wild-type LMP-1 gene was detected in 10/15 cases, whereas in 5/15 cases the LMP-1 gene harbored a deletion spanning codons 346-355. EBV type-1 occurred in 11/15 PEL whereas EBV type-2 occurred in 4/15 cases. Despite a high degree of genetic variability of the virus in different PEL cases, each single PEL harbored only one EBV variant, consistent with monoclonality of infection and suggesting that infection preceded clonal expansion. Overall, our results indicate that: (1) individual PEL cases consistently harbor a single EBV strain; (2) EBNA-1 displays a high degree of heterogeneity in different PEL cases; (3) no specific EBV genotype preferentially associates with PEL.
Fassone
L
L
Division of Internal Medicine, Department of Medical Sciences, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
Bhatia
K
K
Gutierrez
M
M
Capello
D
D
Gloghini
A
A
Dolcetti
R
R
Vivenza
D
D
Ascoli
V
V
Lo Coco
F
F
Pagani
L
L
Dotti
G
G
Rambaldi
A
A
Raphael
M
M
Tirelli
U
U
Saglio
G
G
Magrath
I T
IT
Carbone
A
A
Gaidano
G
G
D004279:DNA, Viral / Q000302:isolation & purification; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D015972:Gene Expression Regulation, Neoplastic; D015967:Gene Expression Regulation, Viral; D005838:Genotype; D006566:Herpesviridae Infections / Q000150:complications*; D019288:Herpesvirus 8, Human / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000737:chemistry / Q000821:virology*; D009154:Mutation; D017422:Sequence Analysis, DNA; D014407:Tumor Cells, Cultured; D014764:Viral Proteins / Q000032:analysis* / Q000737:chemistry
D004279:DNA, Viral; C402640:EBNA-LP protein, Human herpesvirus 4; D014764:Viral Proteins